Insider Trading March 2, 2026

First Financial Bancorp internal auditor disposes $9,036 in stock amid strong quarterly results and fresh analyst coverage

Chief Internal Auditor James R. Shank sells 320 shares as the bank posts record Q4 2025 results and draws Neutral coverage from Brean Capital

By Hana Yamamoto FFBC
First Financial Bancorp internal auditor disposes $9,036 in stock amid strong quarterly results and fresh analyst coverage
FFBC

James R. Shank, Chief Internal Auditor at First Financial Bancorp (FFBC), sold 320 shares on February 27, 2026, for $9,036. The bank reported record Q4 2025 earnings and revenue, while Brean Capital initiated coverage with a Neutral rating and a $33.00 price target. Market metrics and third-party research highlight differing views on valuation.

Key Points

  • Insider transaction: Chief Internal Auditor James R. Shank sold 320 shares on February 27, 2026, at $28.24 per share, totaling $9,036; he retains 10,821 shares.
  • Company performance: First Financial Bancorp reported record Q4 2025 adjusted EPS of $0.80 (vs. $0.56 forecast) and record revenue of $251.3 million, slightly above expectations.
  • Analyst coverage and valuation: InvestingPro lists FFBC on its Most Undervalued list while Brean Capital initiated coverage with a Neutral rating and a $33.00 price target; Brean’s FY26 and FY27 EPS forecasts are $3.10 and $3.30 versus consensus of ~ $3.13 and $3.40.

James R. Shank, who serves as Chief Internal Auditor at First Financial Bancorp (NASDAQ:FFBC), executed a sale of 320 shares of the company’s common stock on February 27, 2026. The transaction took place at $28.24 per share and totaled $9,036. After completing this sale, Shank directly holds 10,821 shares of First Financial Bancorp.

The bank’s shares are quoted at $28.08, placing the regional bank at a market capitalization of $2.79 billion and a price-to-earnings ratio of 10.59. Independent platform InvestingPro flags FFBC as appearing undervalued at current levels and lists the stock on its Most Undervalued list. The platform also notes access to an in-depth Pro Research Report and provides exclusive ProTips that reference the company’s 44-year dividend track record, alongside more than 1,400 Pro Research reports available for U.S. equities.

First Financial Bancorp’s recent operating results showed record performance in the fourth quarter of 2025. Adjusted earnings per share reached $0.80, outpacing the consensus forecast of $0.56. The company also recorded record revenue of $251.3 million, a figure described as slightly above expectations.

In addition to the company’s reported results, Brean Capital has opened coverage on First Financial Bancorp with a Neutral rating and established a $33.00 price target. Brean analyst John Rodis estimated fiscal year 2026 and 2027 earnings per share of $3.10 and $3.30, respectively. These projections compare with current consensus estimates of roughly $3.13 for FY26 and $3.40 for FY27.

Taken together, the disclosures in recent days include a modest insider sale by a senior audit executive, a quarter of record operating metrics for the bank, and the initiation of outside analyst coverage that characterizes the bank’s outlook as cautious despite strong near-term results. The data points reflect both a favorable set of quarterly outcomes and a range of third-party opinions on valuation and forward earnings.


Summary

James R. Shank sold 320 shares of First Financial Bancorp on February 27, 2026, for $9,036 and now holds 10,821 shares. The stock trades at $28.08 with a market cap of $2.79 billion and a P/E of 10.59. InvestingPro lists FFBC as Most Undervalued. The bank posted record Q4 2025 adjusted EPS of $0.80 and revenue of $251.3 million. Brean Capital initiated coverage with a Neutral rating and a $33.00 price target, forecasting FY26 and FY27 EPS of $3.10 and $3.30, versus consensus of about $3.13 and $3.40.

Risks

  • Analyst uncertainty - Brean Capital’s Neutral initiation and conservative EPS projections for FY26 and FY27 suggest caution among some market analysts, which could affect investor sentiment in the banking and financials sector.
  • Valuation disagreement - Contrasting signals from InvestingPro (listing FFBC as Most Undervalued) and Brean Capital (Neutral with a $33.00 target) indicate differing views on current valuation and near-term earnings, posing uncertainty for valuation assessments in financial services.
  • Insider activity interpretation - The modest sale by a senior internal auditor may be scrutinized by investors despite the small monetary value, introducing potential short-term focus on insider transactions within the banking sector.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026